Cis-Curon Iv Injection 2Mg/Ml

Name: Cis-Curon Iv Injection 2Mg/Ml
Brand: Brookes Pharma Private Limited
Price: 604.37

Brand : brookes pharma private limited

Rs. 604.37

Rs. 636.18

|

QUICK DELIVERY

Cis-Curon Iv Specification

Requires Prescription (YES/NO)

Yes

Generics

Cis-atracurium Besylate

Used For

Anesthesia

How it works

Cisatracurium, a stereoisomer of atracurium, is an intermediate duration, non-depolarising benzylisoquinolinium skeletal muscle relaxant. Cisatracurium besylate binds to cholinergic receptors on the motor end-plate to antagonise the action of acetylcholine, resulting in a competitive block of neuromuscular transmission. This action is readily reversed by anticholinesterase agents such as neostigmine.

Cis-Curon Iv Usage And Safety

Dosage

Cis-atracurium Besylate

Side Effects

Cardiovascular : Bradycardia (0.4%), hypotension (0.2%), flushing (0.2%). Respiratory : Bronchospasm (0.2%). Dermatological: Rash (0.1%). Hypersensitivity : Very rarely : Severe anaphylactic reactions have been reported in patients receiving Cis-Curon Injection in conjunction with one or more anaesthetic agents.

Drug Interactions

Enflurane , isoflurane , halothane , ketamine , aminoglycosides , polymyxin , spectinomycin , tetracyclines , linomycin , clindamycin , propranolol calcium-channel blockers , lignocaine , procaineamide , quninidine , furosemide , thiazides , mannitol , acetazolamide , phenytoin , carbamazepine .

Indication

As an adjunct to general anaesthesia. To facilitate non-emergency endotracheal intubation . To provide skeletal muscle relaxation during surgery or mechanical ventilation.

When not to Use

Cis-atracurium Besylate Injection is contraindicated in patients known to be hypersensitive to cisatracurium besylate, atracurium besylate or benzenesulfonic acid .

Cis-Curon Iv Precautions

Precaution

It is essential to maintain pulmonary ventilation and arterial oxygenation until adequate spontaneous respiration returns.

Cis-Curon Iv Warnings

Warning 1

Prolonged muscle paralysis and its consequences are expected to be the main signs of overdose with Cis-atracurium Besylate Injection.

Warning 2

Full sedation will be required since consciousness is not impaired by Cis-atracurium Besylate Injection .

Warning 3

Recovery may be accelerated by the administration of anticholinesterase agents once evidence of spontaneous recovery is present.

Download the Dvago App